Intravenous Thrombolytic Treatment in the Oldest Old
Background and Purpose. Intravenous thrombolysis using tissue plasminogen activator is safe and probably effective in patients >80 years old. Nevertheless, its safety has not been specifically addressed for the oldest old patients (≥85 years old, OO). We assessed the safety and effectiveness of t...
Saved in:
| Main Authors: | Juan García-Caldentey, María Alonso de Leciñana, Patricia Simal, Blanca Fuentes, Gemma Reig, Fernando Díaz-Otero, Marta Guillán, Ana García, Patricia Martínez, Andrés García-Pastor, José Antonio Egido, Exuperio Díez-Tejedor, Antonio Gil-Núñez, José Vivancos, Jaime Masjuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Stroke Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2012/923676 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simple prediction model for unfavorable outcome in ischemic stroke after intravenous thrombolytic therapy
by: Daniel Amitrano, et al. -
Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies
by: Jesús Prego-Domínguez, et al.
Published: (2025-02-01) -
Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics.
by: Jun Young Chang, et al.
Published: (2017-01-01) -
The Oldest Art
by: Byron Breedlove
Published: (2025-05-01) -
The oldest animal fossils
by: Robert Gess
Published: (2012-01-01)